Accendra Health, Inc. Foreign Income Tax Expense (Benefit), Continuing Operations
Accendra Health, Inc. (ACH) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $1.64 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-20
- Accendra Health, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2025 was $1.64M, a 226.24% increase from fiscal 2024.
- Accendra Health, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2024 was $503.00K, a 177.90% increase from fiscal 2023.
- Accendra Health, Inc. foreign income tax expense (benefit), continuing operations for fiscal 2023 was $181.00K.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $1.64M 10-K · filed 2026-02-20 |
| 2024-12-31 | $503.00K 10-K · filed 2026-02-20 |
| 2023-12-31 | $181.00K 10-K · filed 2026-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |